Event Summary: ASGCT 2026 Annual Meeting
Cell and Gene Therapy Insights · 17.06.2026 · 12 (5)
DOI: 10.18609/cgti.2026.063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell and Gene Therapy Insights, online erschienen am 17.06.2026. Verfasst von Abigail Pinchbeck. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
At the end of May, I had the pleasure of attending the 2026 ASGCT Annual Meeting in Boston. Now in its 29th year, the meeting remains the premier gathering for the cell and gene therapy community, and this year did not disappoint. Over several packed days, the program brought together researchers, clinicians, developers, and advocates working across the full spectrum of the field – from foundational vector biology to first-in-human programs and emerging editing platforms. Here are some of the sessions that stood out most to me.
Zitieren
APA
Pinchbeck, A. (2026). Event Summary: ASGCT 2026 Annual Meeting. Cell and Gene Therapy Insights, 12(5). https://doi.org/10.18609/cgti.2026.063
Vancouver
Pinchbeck A. Event Summary: ASGCT 2026 Annual Meeting. Cell and Gene Therapy Insights. 2026;12(5). doi:10.18609/cgti.2026.063
BibTeX
@article{Pinchbeck2026,
author = {Pinchbeck, Abigail},
title = {Event Summary: ASGCT 2026 Annual Meeting},
journal = {Cell and Gene Therapy Insights},
year = {2026},
volume = {12},
number = {5},
doi = {10.18609/cgti.2026.063}
}
EUVIMED